RAP PLATFORM
Live / Registered — Registered (as of 22 Jul 2025)
What this means for you
Registered since 22 Jul 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97768059
- Registration number
- 7870935
- Mark type
- Stylized text
- Filed
- 25 Jan 2023
- Published for opposition
- 12 Mar 2024
- Registered
- 22 Jul 2025
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 042 — Scientific and technological services: Research and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents for the treatment of a variety of human and animal diseases and disorders, namely, autoimmune diseases and disorders, cardiovascular diseases and disorders, connective tissues diseases and disorders, dermatological diseases and disorders, enzyme deficiency diseases and disorders, gastrointestinal diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hematological diseases and disorders, immunoregulatory diseases and disorders, infectious diseases and disorders, inflammatory diseases and disorders, hepatic diseases and disorders, metabolic diseases and disorders, muscular diseases and disorders, neurological diseases and disorders, neuromuscular diseases and disorders, oncological diseases and disorders, ophthalmological diseases and disorders, rare diseases and disorders, renal diseases and disorders, reproductive disease and disorders, and respiratory diseases and disorders; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; pharmaceutical drug development and drug discovery services; pharmaceutical research and analysis services using machine learning analytics relating to pharmaceutical drug development; scientific research, pharmaceutical research, medical research, technical consultation, and product development for others in the field of biotechnology and development of pharmaceutical, therapeutic, and biopharmaceutical preparations and agents
Owner
- CAMP4 Therapeutics Corporation, Cambridge, MA, US
- CAMP4 Therapeutics Corporation, Cambridge, MA, US
- CAMP4 Therapeutics Corporation, Cambridge, MA, US
Prosecution history
- 22 Jul 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Jul 2025 — REGISTERED-PRINCIPAL REGISTER
- 16 Jul 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Jun 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Jun 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 07 Nov 2024 — USE AMENDMENT FILED
- 07 Nov 2024 — TEAS STATEMENT OF USE RECEIVED
- 07 May 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Mar 2024 — PUBLISHED FOR OPPOSITION
- 21 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Feb 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Feb 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Feb 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Feb 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE